IL22433A - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- IL22433A IL22433A IL2243364A IL2243364A IL22433A IL 22433 A IL22433 A IL 22433A IL 2243364 A IL2243364 A IL 2243364A IL 2243364 A IL2243364 A IL 2243364A IL 22433 A IL22433 A IL 22433A
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/22—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing two or more pyridine rings directly linked together, e.g. bipyridyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32327163A | 1963-11-13 | 1963-11-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL22433A true IL22433A (en) | 1968-02-26 |
Family
ID=23258443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL2243364A IL22433A (en) | 1963-11-13 | 1964-11-12 | Pharmaceutical compositions |
Country Status (5)
Country | Link |
---|---|
BE (1) | BE655636A (en) |
FR (1) | FR3908M (en) |
GB (1) | GB1073708A (en) |
IL (1) | IL22433A (en) |
NL (1) | NL6413212A (en) |
-
1964
- 1964-11-12 BE BE655636A patent/BE655636A/xx not_active Expired
- 1964-11-12 GB GB46223/64A patent/GB1073708A/en not_active Expired
- 1964-11-12 NL NL6413212A patent/NL6413212A/xx unknown
- 1964-11-12 FR FR994611A patent/FR3908M/fr not_active Expired
- 1964-11-12 IL IL2243364A patent/IL22433A/en unknown
Also Published As
Publication number | Publication date |
---|---|
NL6413212A (en) | 1965-05-14 |
BE655636A (en) | 1965-03-01 |
FR3908M (en) | 1966-02-07 |
GB1073708A (en) | 1967-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY6600045A (en) | Explosive compositions | |
CY572A (en) | Novel basic ethers and pharmaceutical compositions containing the same | |
USD202467S (en) | Pharmaceutical tablets | |
MY6900365A (en) | Wood-treatment compositions | |
IL22433A (en) | Pharmaceutical compositions | |
IE27478L (en) | Pharmaceutical composition | |
AU287999B2 (en) | Pharmaceutical compositions | |
AU284428B2 (en) | Pharmaceutical compositions | |
CA672940A (en) | Pharmaceutical compositions | |
AU278747B2 (en) | Pharmaceutical compositions | |
AU278760B2 (en) | Pharmaceutical compositions | |
AU281371B2 (en) | New pharmaceutical compositions | |
AU4664864A (en) | Pharmaceutical compositions | |
AU4969664A (en) | Pharmaceutical compositions | |
AU4212364A (en) | Pharmaceutical compositions | |
AU3047863A (en) | Pharmaceutical compositions | |
IE27635L (en) | Emollient compositions | |
AU4771064A (en) | New pharmaceutical compositions | |
IE26299L (en) | Pharmaceutical compositions | |
CA663640A (en) | Therapeutic compositions | |
CA661922A (en) | Therapeutic compositions | |
CA662816A (en) | Therapeutic compositions comprising 5-nitrofurfurylidenecarbazates | |
CA658959A (en) | Polychloroprene-asphalt compositions | |
CA656502A (en) | Polyethylene-wax compositions | |
CA669979A (en) | Steroid-flavonoid compositions |